Arthritis & Rheumatism. 2006;54(12):3859-3867. Degenerative disc disease is one of today's most common and costly medical conditions. Marked by the gradual erosion of cartilage between the ...

Medically reviewed by Mohamad Hassan, PTMedically reviewed by Mohamad Hassan, PT You may be able to prevent degenerative disc disease (DDD ... recommended for more severe cases and involves ...

Surgery is typically indicated when six months of conservative therapy have not been successful, if there is a neurologic deficit attributable to the cervical disc disease or when the symptoms ...

New data suggest the frequency of damage and repair processes correlates with disease severity and disability in multiple ...

For this reason, not many adults get it. If you do get fifth disease as an adult, you typically won’t get the rash, but you could get severe flu-like symptoms (sore muscles, coughing ...

Bone-related disorders encompass pathologies ranging from orthopedic conditions, such as severe fractures, to spinal conditions, such as degenerative disc disease. Despite the growing number of ...

Compared with changes seen in the normal population (non-athletes) as described in the literature, disc degeneration defined by the above criteria was found to be significantly more severe in these ..

Macular degeneration, also known as age-related macular degeneration (AMD), is an eye disease that causes ... macular ...

Sep. 26, 2024 — What factors lead to chronic respiratory disease? Researchers investigated ... test to identify adults most likely to develop severe respiratory conditions, including chronic ...

With wet AMD, abnormal blood vessels grow under the macula. The wet form of age-related macular degeneration can start suddenly. You won’t feel pain, but you might notice vision problems.

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Dr. Robert A. Hauser, professor of neurology at the University of South Florida said in a press ...

AbbVie has finally won Food and Drug Administration approval of its Vyalev therapy for patients with advanced Parkinson's disease. AbbVie on Thursday said the FDA green light makes Vyalev the ...